Genadur
- Generic Name: hydrosoluble nail lacquer
- Brand Name: Genadur
side effects drug center genadur (hydrosoluble nail lacquer) drug
Drug Description
Genadur
(hydrosoluble nail lacquer)
For Topical Use Only
DESCRIPTION
Genadur is a hydrosoluble nail lacquer.
Ingredients
Diethylene glycol monoethylether, equisetum arvense extract, ethanol, hydroxypropyl chitosan, methyl sulfonyl methane, water.
Indications & Dosage
INDICATIONS
Genadur is indicated to protect intact or damaged nails from the effects of moisture, friction (rubbing) or shear (tearing), relieving symptoms and signs of nail dystrophy (i.e. nail splitting and fragility).
DOSAGE AND ADMINISTRATION
Directions
Apply Genadur once daily to clean and dry nails. Using the supplied brush, apply a thin layer of the product on the affected nail(s). Close bottle immediately after use. The film is hydrosoluble, therefore Genadur should be applied after nail washing and drying, preferably before bedtime. Genadur may also be used under a cosmetic colored nail polish, thus protecting the nails from the damaging action of solvents used for polish removal.
HOW SUPPLIED
Genadur Hydrosoluble Nail Lacquer is available in a 12 mL bottle with applicator brush, 43538-510-12.
Store at 15°C to 30°C (59°F to 86°F). Protect from heat.
Mfd. for: Medimetriks Pharmaceuticals, Inc., 383 Route 46 West, Fairfield, NJ 07004-2402 USA. Mfd. by: Polichem S.A., Via Senago 42D, 6912, Lugano-Pazzallo, Switzerland Made in Italy. Revised: Feb 2016
Side Effects & Drug Interactions
SIDE EFFECTS
No information provided.
DRUG INTERACTIONS
No information provided.
Warnings & Precautions
WARNINGS
Do not use on open wounds. Do not ingest.
FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.
PRECAUTIONS
No information provided.
Overdosage & Contraindications
OVERDOSE
No information provided.
CONTRAINDICATIONS
Genadur is contraindicated in persons with known hypersensitivity to any components of the formulation.
Clinical Pharmacology
No information provided.
Medication Guide
PATIENT INFORMATION
No information provided. Please refer to the WARNINGS and PRECAUTIONS sections.